Purchase Order 75N91024P00526

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

<p>This is a $11,840 firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Abiosciences Inc. for single-nuclear sequencing advanced data analysis services. The contract has an ultimate completion date of November 16, 2021 and is not associated with a set-aside program. The award is for services related to NICHD's research and development efforts.</p>

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>

<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>

<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Creative Biolabs Inc., a for-profit biotechnology and pharmaceutical services company. The $9,980.00 contract is for lab testing services and does not have a set-aside designation. Creative Biolabs has a history of securing federal contracts from various civilian agencies, including the NIH and its specialized institutes, to provide advanced...

This contract was awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Integrated Biotherapeutics, LLC (doing business as IBT Bio Services), a small disadvantaged business. The $17,964 firm fixed-price purchase order is for laboratory and testing services, with a period of performance ending on May 26, 2026. IBT Bio Services has a history of providing biomedical research and infectious disease response services to federal agencies through prior contract...

This is a $19,980.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Cancer Institute to Creative Biolabs Inc. for laboratory testing services. The contract has a period of performance from May 15, 2024 to July 10, 2024 and does not have a set-aside designation. Creative Biolabs Inc. is a for-profit organization that specializes in providing custom biotechnology and pharmaceutical services to support federal...